Potassium Chloride for Oral Solution

Product NDC: 62250-690
11-digit product format: 622500690
Labeler code: 62250
Product ID: 62250-690_efe3b2eb-5c29-3783-e053-2995a90a6ba8
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Potassium Chloride for Oral Solution
Dosage form: POWDER, FOR SOLUTION
Route: ORAL
Labeler: Belcher Pharmaceuticals LLC
Application: ANDA212183
Marketing category: ANDA
Marketing start: 2018-06-06
Marketing end: 0000-00-00
Substance: POTASSIUM CHLORIDE
Active strength: 2 g/1.58g
Pharmacologic classes: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	62250-690		I	Inactivated by FDA	2026-08-17
excluded package	package	62250-690	62250-690-32	I	Inactivated by FDA	2026-08-17
excluded package	package	62250-690	62250-690-33	I	Inactivated by FDA	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 27 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62250-690-33	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62250-690-32	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62250-690-33	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62250-690-32	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62250-690-33	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62250-690-32	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62250-690-33	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62250-690-32	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62250-690-33	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62250-690-32	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62250-690-33	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62250-690-32	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62250-690-33	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62250-690-32	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62250-690-33	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62250-690-32	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62250-690-33	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62250-690-32	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A212183-001	POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA		2019-05-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A212183-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A212183-001	POTASSIUM CHLORIDE	20MEQ	FOR SOLUTION / ORAL	AA	2019-05-06	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A212183-001	AA	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A212183-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212183-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A212183-001	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A212183-001	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A212183-001	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A212183-001	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A212183-001	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A212183-001	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A212183-001	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A212183-001	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A212183-001	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A212183-001	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A212183-001	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A212183-001	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A212183-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A212183-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A212183-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A212183-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A212183-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A212183-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A212183-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A212183-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A212183-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A212183-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A212183-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A212183-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A212183-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A212183-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A212183-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A212183-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A212183-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A212183-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A212183-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A212183-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A212183-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A212183-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A212183-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A212183-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A212183-001	AA	1	`e64feba35796…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
d9771140-739b-484b-ae64-b79528ff1211	Product name	3	20250801
efd58dcf-540a-4531-8766-e713129ca6f2	Product name	1	20250307
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62250-690-32	2025-01-30	C162847	48780-1	2cef2736-a44b-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use POTASSIUM CHLORIDE FOR ORAL SOLUTION safely and effectively. See full prescribing information for POTASSIUM CHLORIDE FOR ORAL SOLUTION. POTASSIUM CHLORIDE for oral solution Initial U.S. Approval: 1948
62250-690-33	2025-01-30	C162847	48780-1	2cef2736-a44b-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use POTASSIUM CHLORIDE FOR ORAL SOLUTION safely and effectively. See full prescribing information for POTASSIUM CHLORIDE FOR ORAL SOLUTION. POTASSIUM CHLORIDE for oral solution Initial U.S. Approval: 1948

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
62250-690-32	Potassium Chloride for Oral Solution	30 in 1 CARTON	POWDER, FOR SOLUTION	30	6
62250-690-33	Potassium Chloride for Oral Solution	100 in 1 CARTON	POWDER, FOR SOLUTION	100	6
62250-690-34	Potassium Chloride for Oral Solution	1.58 g in 1 POUCH	POWDER, FOR SOLUTION	1.58	6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62250-690	POTASSIUM CHLORIDE FOR ORAL SOLUTION POWDER, FOR SOLUTION [BELCHER PHARMACEUTICALS LLC]	6	Legacy NDC, 3 package rows	20231006_0e4fd822-9167-4451-b8fe-9a63e09f7ed1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Potassium Chloride for Oral Solution	POTASSIUM CHLORIDE FOR ORAL SOLUTION	BPI Labs LLC	1ea4345e-f8bb-4d41-9003-c87b21169d7c	2026-01-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212183 application number: ANDA212183
Potassium Chloride for Oral Solution	POTASSIUM CHLORIDE FOR ORAL SOLUTION	Ajenat Pharmaceuticals LLC	c62c5704-3667-4d4f-8230-3f7f5ed825b1	2025-12-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212183 application number: ANDA212183
Potassium Chloride for Oral Solution	POTASSIUM CHLORIDE FOR ORAL SOLUTION	Marlex Pharmaceuticals Inc	3e78028d-21a0-ba0f-e063-6294a90aac49	2025-08-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212183 application number: ANDA212183
Potassium Chloride for Oral Solution	POTASSIUM CHLORIDE FOR ORAL SOLUTION	Marlex Pharmaceuticals, Inc.	3e8a6f61-44eb-4b5a-e063-6294a90a4b1b	2025-08-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212183 application number: ANDA212183

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
660YQ98I10	POTASSIUM CHLORIDE	7447-40-7	POTASSIUM CHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1867544	potassium chloride 20 MEQ (1.5 GM) Powder for Oral Solution	PSN	0e4fd822-9167-4451-b8fe-9a63e09f7ed1	6
1867544	potassium chloride 20 MEQ Powder for Oral Solution	SCD	0e4fd822-9167-4451-b8fe-9a63e09f7ed1	6
1867544	K+ Chloride 20 MEQ Powder for Oral Solution	SY	0e4fd822-9167-4451-b8fe-9a63e09f7ed1	6
1867544	Pot Chloride 20 MEQ Powder for Oral Solution	SY	0e4fd822-9167-4451-b8fe-9a63e09f7ed1	6
1867544	potassium chloride 1.5 GM Powder for Oral Solution	SY	0e4fd822-9167-4451-b8fe-9a63e09f7ed1	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
62250-690-32	62250069032	30 POUCH in 1 CARTON (62250-690-32) > 1.58 g in 1 POUCH (62250-690-34)	30 pouch	2018-06-06	0000-00-00	No	No	Current
62250-690-33	62250069033	100 POUCH in 1 CARTON (62250-690-33) > 1.58 g in 1 POUCH (62250-690-34)	100 pouch	2018-06-06	0000-00-00	No	No	Current
62250-690-34	62250069034	1.58 g in 1 POUCH	1.58 g					Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Potassium Chloride for Oral Solution	Belcher Pharmaceuticals LLC	2023-10-05	HUMAN PRESCRIPTION DRUG LABEL	6